HD-OPM Archive
Topics › Lp(a)

High Lp(a) risk offset by about 19 mg/dL lower lifelong LDL-C in UK Biobank analysis

Louis Nervegna · Oct 23, 2025 · ♥ 13 reactions · 6 comments · original Facebook post
Lp(a)LDL, ApoB & lipid panel
AI summary & key facts

Louis shares a TCTMD report on a Ference analysis of 445,765 UK Biobank participants using genetic (natural randomization) methods. Lifelong high Lp(a) was associated with a projected 37% higher risk of major coronary events, completely offset by lower lifetime LDL-C; the later LDL lowering starts, the larger the reduction required.

TCTMD.comElevated Risks From Lp(a) Can Be Offset by Lower Lifetime LDL CholesterolTo get this benefit, people with high Lp(a) need to maintain LDL-cholesterol levels 20 mg/dL lower than if they had normal Lp(a).tctmd.com

Quoted:

MILAN, Italy—Patients can overcome the added risk of coronary heart disease events associated with elevated lipoprotein(a) levels if they maintain lower LDL-cholesterol levels over their lifespan, according to a new analysis from UK Biobank.

For people with high levels of Lp(a)—defined as approximately 120 nmol/L—this requires lifetime LDL-cholesterol levels that are approximately 20 mg/dL lower than those of individuals without elevated Lp(a) to offset the associated risks of atherogenic lipoprotein.

The purpose of the present study, said Ference, was to quantify the amount of LDL-lowering that would be needed to overcome the increased risk caused by Lp(a). To do this, they studied 445,765 patients enrolled in the UK Biobank without a history of ASCVD, diabetes, or cancer before age 30 years. For the natural randomization study, patients were randomly allocated based on genetic variants to either the average Lp(a) values, to “higher” levels (20 nmol/L vs 123 nmol/L, respectively), or to both higher Lp(a) levels and low LDL cholesterol levels.

Based on the calculations, the lifelong exposure to higher Lp(a) levels was associated with a projected 37% higher risk of major coronary events. However, for patients randomized to higher Lp(a) values and lower LDL-cholesterol levels, the risk of coronary events was completely attenuated.

To overcome the 30% to 40% higher risk of major coronary events associated with higher Lp(a) concentrations, LDL-cholesterol levels must be 0.5 mmol/L (19 mg/dL) lower at every single age. The finding was similar in men and women.

Ference pointed out that the benefits of lowering LDL cholesterol deteriorate the later treatment is started in life. With that in mind, the researchers modeled the magnitude of LDL-lowering as a strategy to overcome the risk caused by Lp(a) if treatment was started at different stages in life.

In a patient with Lp(a) 150 nmol/L higher than the median, a 0.6-mmol/L reduction in LDL cholesterol is needed to offset the lifetime risk of Lp(a) if treatment is started at age 30. If LDL-lowering is started at 40, 50, or 60 years, however, lifetime reductions in LDL cholesterol of 0.7, 0.9, and 1.1 mmol/L (27, 35, and 42.5 mg/dL) are needed, respectively. For the people with substantially elevated Lp(a), say 250 nmol/L above the median, starting LDL cholesterol-lowering at age 50 or 60 years would require LDL reductions of 1.5 and 1.9 mmol/L (58 and 73.5 mg/dL) to overcome the increased risk associated with Lp(a).

“The later we start, we require a progressively larger absolute magnitude of LDL-lowering to overcome that increased risk,” Ference said.

#lpaHD #ldlHD #lpaldlHD

Research cited

← newer: Untreated midlife hearing loss causes about 7% of dementia colder: Influencers citing only 1960s-70s studies or post-hoc RCT an →